Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma

AIM: Rituximab has dramatically improved the survival of patients with non-Hodgkin's lymphomas (NHL), but the dosing regimen currently used should be optimized. However, the concentration–effect relationship of rituximab has never been described by pharmacokinetic–pharmacodynamic (PK–PD) modell...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ternant, David, Hénin, Emilie, Cartron, Guillaume, Tod, Michel, Paintaud, Gilles, Girard, Pascal
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Blackwell Science Inc 2009
Onderwerpen:
Pharmacokinetic Dynamic Relationships
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2780281/
https://ncbi.nlm.nih.gov/pubmed/19843059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2009.03494.x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items